SEC Form D private-offering filing

SonoThera, Inc.

A new SEC Form D private-offering notice from South San Francisco, CA, a $125,450,218 filer-stated offering target in Biotech. The source filing is one click away.

SonoThera, Inc. site↗ Verified via SEC Form D

Develops an ultrasound guided, nonviral gene therapy delivery platform (RIPPLE) for genetic medicines targeting diseases like Duchenne muscular dystrophy and polycystic kidney disease.

Filed 2026-06-30Filed to raise $125,450,218First money in 2026-06-08Raised so far $125,450,218HQ (as filed) South San Francisco, CASector Biotech ✓Stage (inferred) LateCall status Delayed filing
Source linked the Form D on EDGAR↗Website verified sonothera.com↗Named in the filing 8 executives & directors
Open this row on the live feed →More new filings in California →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.